Nyt navn og nye behandlinger for primær biliær kolangitis

Lars Bossen; Henriette Ytting; Peter Jepsen; Ole Hamberg; Peter Ott; Henning Grønbæk

Nyt navn og nye behandlinger for primær biliær kolangitis

Lars Bossen, Henriette Ytting, Peter Jepsen, Ole Hamberg, Peter Ott, Henning Grønbæk

Abstract

The name of chronic liver disease: primary biliary cirrhosis, has been changed to: primary biliary cholangitis, primarily because of the stigma associated with the word "cirrhosis", as only a minority of the patients develop cirrhosis. In this review we present data on epidemiology and discuss the current treatments with focus on ursodeoxycholic acid and the newly described effects of the farnesoid receptor agonist obeticholic acid.

Bidragets oversatte titel	New name and new treatments for primary biliary cholangitits
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	10
Sider (fra-til)	V07170531
ISSN	0041-5782
Status	Udgivet - 5 mar. 2018

Citationsformater

@article{5778c292b1984f36aa98f1c0366397b9,

title = "Nyt navn og nye behandlinger for prim{\ae}r bili{\ae}r kolangitis",

abstract = "The name of chronic liver disease: primary biliary cirrhosis, has been changed to: primary biliary cholangitis, primarily because of the stigma associated with the word {"}cirrhosis{"}, as only a minority of the patients develop cirrhosis. In this review we present data on epidemiology and discuss the current treatments with focus on ursodeoxycholic acid and the newly described effects of the farnesoid receptor agonist obeticholic acid.",

author = "Lars Bossen and Henriette Ytting and Peter Jepsen and Ole Hamberg and Peter Ott and Henning Gr{\o}nb{\ae}k",

year = "2018",

month = mar,

day = "5",

language = "Dansk",

volume = "180",

pages = "V07170531",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "10",

}

TY - JOUR

T1 - Nyt navn og nye behandlinger for primær biliær kolangitis

AU - Bossen, Lars

AU - Ytting, Henriette

AU - Jepsen, Peter

AU - Hamberg, Ole

AU - Ott, Peter

AU - Grønbæk, Henning

PY - 2018/3/5

Y1 - 2018/3/5

N2 - The name of chronic liver disease: primary biliary cirrhosis, has been changed to: primary biliary cholangitis, primarily because of the stigma associated with the word "cirrhosis", as only a minority of the patients develop cirrhosis. In this review we present data on epidemiology and discuss the current treatments with focus on ursodeoxycholic acid and the newly described effects of the farnesoid receptor agonist obeticholic acid.

AB - The name of chronic liver disease: primary biliary cirrhosis, has been changed to: primary biliary cholangitis, primarily because of the stigma associated with the word "cirrhosis", as only a minority of the patients develop cirrhosis. In this review we present data on epidemiology and discuss the current treatments with focus on ursodeoxycholic acid and the newly described effects of the farnesoid receptor agonist obeticholic acid.

M3 - Tidsskriftartikel

C2 - 29536837

SN - 0041-5782

VL - 180

SP - V07170531

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 10

ER -

Nyt navn og nye behandlinger for primær biliær kolangitis

Abstract

Fingeraftryk

Citationsformater